Event: Pharma China Seminar 2010 - Building Success in China's Pharma Sector
Date(s): April 29, 2010 and November 4, 2010
Venue: Crowne Plaza Fairfield, Fairfield, New Jersey
Weblink: www.pharmachinaseminar.com

Brochure: PharmaChinaSeminar-2010.pdf
Contact: Amy Yueh
Tel: +1 212-2287974 or +1 713-3986888
Email: info@pharmachinaseminar.com

China's enormous size, its ageing population, consistent double-digit pharmaceutical industry growth in the past two decades and ongoing healthcare reform have convinced even the most conservative industry analysts to offer optimistic views about its future.

For many pharmaceutical MNCs, China is now a leading overseas market and it is likely to become their largest foreign market within a decade. Moreover, China has recently become a favorite destination for innovative drug R&D and many big pharma MNCs are increasingly relocating and outsourcing their R&D to the country. Finally, MNCs are also expanding their Chinese production operations and outsourcing more manufacturing projects to China.

Nevertheless, the pharmaceutical industry in China continues to face mounting challenges and the ever-changing legal, regulatory and market environments of China's healthcare sector pose the single biggest challenge to foreign companies.  

There are success stories from all categories of players, whether they are foreign or local, large or small, newcomer or established, private or state-owned. However, to be one of the success stories requires a thorough understanding of the sector, ability to face and tackle challenges, flexibility to deal with changes, and skills to maneuver through complex situations.

To cater for the growing needs of headquarter pharmaceutical executives for better understanding of the Chinese market, the Seminar was jointly launched in 2009 by AmIntell, the organizer of Pharma CI Conference and Pharma Market Research Conference, and Pharma China, the most influential English media and source of business intelligence covering the Chinese pharmaceutical / biopharmaceutical industry and market.

"Pharma China Seminar - Building Success in China's Pharma Sector" is a one-day seminar providing insights into contemporary trends/issues and the most important aspects of the Chinese pharmaceutical industry and marketplace today.

On the basis of our successful experience with the event in 2009, Pharma China Seminar 2010 will refocus its agenda to provide more in-depth coverage of and strategic insights into four key aspects of Chinese pharma business including 1) latest trends and issues in drug regulation and healthcare policies, 2) pharma marketing & distribution channels, 3) the regulatory process for new drug development and 4) IP/legal issues.

Four leading experts of the Chinese pharmaceutical/healthcare sector with different specialization will share their expertise and knowledge through exclusive data, detailed analysis, case studies and interactive panel discussions.

Who should attend?

- Senior executives

- Strategic planning/business development/CI/market research executives

- Executives responsible for outsourcing

- R&D/licensing/regulatory executives

- Regional HQ executives

- Expatriate executives in China

- CRO executives

- Investment/VC professionals

- Learn about the present state and future outlook of the Chinese pharma industry and marketplace
- Identify emerging opportunity areas and growth drivers
- Examine major intellectual property issues and legal risks

- Stay informed for the latest developments in Chinese drug regulation and healthcare policy

- Gain insights into key aspects of Chinese pharma business

- Brainstorm successful China business strategies

- Contemporary trends, issues and challenges

- Future growth drivers, opportunities and outlook

- Healthcare reform and impacts on pharma sector

- Intellectual property/patent related issues

- Pricing and reimbursement/health insurance system

- Pharmaceutical marketing and distribution channel strategies

- Regulatory process for new drug development and registration

- Considerations for developing successful China business strategies

- Rising global importance of China – sourcing and licensing opportunities



For more information, please visit www.pharmachinaseminar.com or contact: Amy Yueh at +1 212.228.7974 or +1 713.398.6888 or email info@pharmachinaseminar.com.